The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
The DOI matches its Crossref record; 30 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sleep disorders affect many patients with chronic pain conditions. Cannabis has been reported by several patient populations to help sleep. We evaluated the safety and efficacy of nabilone, a synthetic cannabinoid, on sleep disturbance in fibromyalgia (FM), a disease characterized by widespread chronic pain and insomnia. METHODS: We conducted a randomized, double-blind, active-control, equivalency crossover trial to compare nabilone (0.5-1.0 mg before bedtime) to amitriptyline (10-20 mg before bedtime) in patients with FM with chronic insomnia. Subjects received each drug for 2 wk with a 2-wk washout period. The primary outcome was sleep quality, measured by the Insomnia Severity Index and the Leeds Sleep Evaluation Questionnaire. Secondary outcomes included pain, mood, quality of life, and adverse events (AEs). RESULTS: Thirty-one subjects were enrolled and 29 completed the trial (26 women, mean age 49.5 yr). Although sleep was improved by both amitriptyline and nabilone, nabilone was superior to amitriptyline (Insomnia Severity Index difference = 3.2; 95% confidence interval = 1.2-5.3). Nabilone was marginally better on the restfulness (Leeds Sleep Evaluation Questionnaire difference = 0.5 [0.0-1.0]) but not on wakefulness (difference = 0.3 [-0.2 to 0.8]). No effects on pain, mood, or quality of life were observed. AEs were mostly mild to moderate and were more frequent with nabilone. The most common AEs for nabilone were dizziness, nausea, and dry mouth. CONCLUSIONS: Nabilone is effective in improving sleep in patients with FM and is well tolerated. Low-dose nabilone given once daily at bedtime may be considered as an alternative to amitriptyline. Longer trials are needed to determine the duration of effect and to characterize long-term safety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RCTs using active comparators are lacking, except in two studies.15,20”
From Nabilone for the Management of Pain (2016) · cites this paper as [20]
In the citing paper
“It is important to note, however, that these low doses improved the primary outcome of sleep quality.”
From Nabilone for the Management of Pain (2016) · cites this paper as [20]
In the citing paper
“No between-group differences in pain were observed, which may be explained in part by the once-daily dosing strategy and relatively low doses used.”
From Nabilone for the Management of Pain (2016) · cites this paper as [20]
In the citing paper
“No statistical analysis, however, was conducted.15,20”
From Nabilone for the Management of Pain (2016) · cites this paper as [20]
In the citing paper
“When compared with dihydrocodeine and amitriptyline, patients receiving nabilone had a higher overall occurrence of ADRs.15,20”
From Nabilone for the Management of Pain (2016) · cites this paper as [20]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Validation of the Insomnia Severity Index as an outcome measure for insomnia research
Bastien, C. (2001) · Sleep Medicine · doi:10.1016/s1389-9457(00)00065-4 · Cited by 8,067 · cited 1×
“The ISI is a reliable and valid instrument used to quantify perceived insomnia severity and is used as an outcome measure in insomnia treatment research.(21) A score of 8 on the ISI implies no clinical insomnia, 8–14 implies moderate insomnia, and 15 implies severe insomnia.”
MethodThe short-form McGill pain questionnaire
Melzack, R. (1987) · Pain · doi:10.1016/0304-3959(87)91074-8 · Cited by 4,368
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
(1991) · PubMed · Cited by 1,837
Management of fibromyalgia syndrome
Goldenberg, D. L. (2004) · JAMA · doi:10.1001/jama.292.19.2388 · Cited by 850 · cited 1×
“exercise, cognitive behavioral therapy, and patient education.(16,17) Nabilone, a synthetic cannabinoid, has been observed in a small case series to improve sleep in patients with chronic pain.”
BackgroundShort Form of the Profile of Mood States (POMS-SF): Psychometric information.
Curran, S. L., Andrykowski, M. A., & Studts, J. L. (1995) · Psychological Assessment · doi:10.1037//1040-3590.7.1.80 · Cited by 808
Crofford, L. J., Rowbotham, M. C., Mease, P. J., Russell, I. J., Dworkin, R. H., Corbin, A. E., Young, J. P., LaMoreaux, L. K., Martin, S. A., Sharma, U., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20983 · Cited by 654
White, K. P., Speechley, M. R., Harth, M., & Østbye, T. (1999) · PubMed · Cited by 410
Fibromyalgia patients show an abnormal dopamine response to pain
Wood, P. B., Schweinhardt, P., Jaeger, E., Dagher, A., Hakyemez, H., Rabiner, E. A., Bushnell, M. C., & Chizh, B. A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05623.x · Cited by 406
Cited by
Items 201–288 of 288
Lopera, V., Restrepo, J., & Amariles, P. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100524 · Cited by 16
“However, all adverse events were categorized from mild to moderate; therefore, no serious adverse events were identified in the studies included 26 – 29,47,47 – 49, 51 – 54 in this systematic review.”
BackgroundInfluentialA FAAH-fetched approach to treat osteoarthritis pain
Lichtman, A. H., & Chapman, V. (2011) · Pain · doi:10.1016/j.pain.2011.02.034 · Cited by 5
Study of the effect of Cannabis sativa on liver and brain damage caused by thioacetamide
Abdel‐Salam, O. M. E., El-Shamarka, M. E.-S., Shafee, N., & Gaafar, A. E.-D. M. (2012) · Comparative Clinical Pathology · doi:10.1007/s00580-012-1641-0 · Cited by 5
“Smoking cannabis has also been utilized to lessen neuropathic pain in patients with human immunodeficiency virus (HIV) (Ellis et al. 2009) and for post-traumatic or postsurgical neuropathic pain (Ware et al. 2010b).”
BackgroundTreatment of Fatigue and Sleep Disorders in Cancer Patients
Goforth, H. W., & Davis, M. P. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000070 · Cited by 6
Pharmacological Management of Neuropathic Pain: Current Trends and Possible Approaches
Kumar, A., Pottabathini, R., Bhatnagar, A., Garg, S., & Gupta, V. (2016) · Archives of Neuroscience · doi:10.5812/archneurosci.28998 · Cited by 7
“Although no difference in pain suppression was observed between amitriptyline and nabilone, nabilone was better in improving the quality of sleep and is considered as an alternative to amitriptyline, but its long term safety profile should be assessed further (87).”
Tıbbi Esrar Psikiyatrik Bozuklukların Tedavisinde Kullanılabilir mi?
Tellioğlu, T., & Tellioğlu, Z. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120223123828 · Cited by 6
“0 mg) amitriptilin ile (10-20 mg) değişmeli olarak denenmiş ve uyku her iki grupta da düzelmiş olmasına rağmen, nabilonun daha etkili olduğu ve daha az yan etkiye yol açtığı bildirilmiştir (35).”
Manca, A., Valz, C., Chiara, F., Mula, J., Palermiti, A., Billi, M., Antonucci, M., Nicolò, A. D., Luxardo, N., Imperiale, D., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116686 · Cited by 8
T, G. A. (2015) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482015000300004 · Cited by 5
Giardina, A., Palmieri, R., Ponticelli, M., Antonelli, C., Carlucci, V., Colangelo, M., Benedetto, N., Fazio, A. D., & Milella, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144088 · Cited by 7
Guidelines for the successful management of fibromyalgia patients
Bennett, R. M. (2014) · Indian Journal of Rheumatology · doi:10.1016/j.injr.2014.09.011 · Cited by 3
Advances in the management of fibromyalgia: what is the state of the art?
Staud, R. M. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2071606 · Cited by 3
Cannabinoids for the Treatment of Chronic Pain: A Critical Review of Randomized Controlled Trials
Hassan, S. I. (2018) · Journal of Pain Management & Medicine · doi:10.35248/2684-1320.18.4.131 · Cited by 4
“Methods Trial design: All 21 studies were double-blinded, 15 used a crossover design [27-30].”
MethodTai Chi may be More Effective for Improving Fibromyalgia Symptoms Than Aerobic Exercise
Ostrovsky, D. A. (2018) · EXPLORE · doi:10.1016/j.explore.2018.06.002 · Cited by 3
Review of medicinal use of Cannabis derivatives and the societal impact of legalization
Chaturvedi, P., Malik, A., Fatehi, K., & Menon, N. N. (2020) · Indian Journal of Palliative Care · doi:10.4103/ijpc.ijpc_19_20 · Cited by 3
“3).[22] A randomized controlled trial (RCT) performed across three centers in the United Kingdom (96 patients) had two groups; one received marijuana followed by dihydrocodeine and vice versa was administered in the other group.”
BackgroundQuality of Life in Patients with Fibromyalgia
Tawadros, A. E., Udeoji, D. U., Awad, M., de Castro-Abeger, A. H., Nguyen, T., Bensoussan, J.-C., & IsHak, W. W. (2013) · International Journal of Clinical Psychiatry and Mental Health · Cited by 4
Consider cannabinoids as an individual therapeutic trial in nociplastic pain
Kim, E. S., & Kang, C. (2022) · Drugs & Therapy Perspectives · doi:10.1007/s40267-022-00954-2 · Cited by 2
“Crossover RCT in FM pts with chronic insomnia (n = 32) [7] Nabilone 0.”
BackgroundCannabiskonsum und Cannabiskonsumstörungen
Hoch, E., & Preuss, U. W. (2024) · Der Nervenarzt · doi:10.1007/s00115-024-01722-5 · Cited by 3
The Use of Medical Marijuana in the Treatment of Psychiatric Disorders
Tellioğlu, T., & Tellioğlu, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00105-8 · Cited by 6
EXPLORING THE EFFICACY AND SAFETY OF CANNABIS IN THE MANAGEMENT OF FIBROMYALGIA
Sagdeo, A., Askari, A., Ball, P., & Morrissey, H. (2022) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2022v14i1.44109 · Cited by 2
“approaches used, arising from the wide variations in international regulations and controls, limit their utility as a basis for public health policy [28-31].”
BackgroundFarré, M., Farré, A., Fiz, J., & Torrens, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00112-5 · Cited by 2
Do cannabinoids constitute a therapeutic alternative for insomnia?
Contreras, T., Bravo‐Soto, G., & Gabriel Rada, G. (2018) · Medwave · doi:10.5867/medwave.2018.01.7151 · Cited by 2
Fibromyalgia and Centralized Pain States
Brummett, C. M., & Clauw, D. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40196-8.00026-7 · Cited by 5
A Review on Medicinal Plants Used for Nausea and Vomiting in Persian Medicine
Azadbakht, M., Darvishpor, S., Hosseini, A., Davoodi, A., Salehifar, E., & Akbari, J. (2018) · Global Journal of Medical Research · Cited by 10
Cannabinoids For Fibromyalgia: An Updated Systematic ReviewPreprint
Scicluna, J. C., & Giovanni, G. D. (2022) · medRxiv · doi:10.1101/2022.05.17.22275200 · Cited by 3
“In all 9 studies included in this review (Chaves et al., 2020b; Fiz et al., 2011; Habib & Artul, 2018; Sagy, Schleider, et al., 2019; Skrabek et al., 2008; v. Giorgi1 et al., n.d.; van de Donk et al., 2019; Ware et al., 2010; Yassin et al., 2019), adverse effects were mild to moderate and the major adverse effects see…”
InfluentialChou, R., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., Selph, S., Holmes, R. S., & Fu, R. (2022) · doi:10.23970/ahrqepccannabissurveillance4 · Cited by 3
Feinberg, S. D., Aronoff, G. M., Ausfahl, J., Bruns, D., Darnall, B. D., Goldberg, R. L., Haldeman, S., Lessenger, J. E., Mandel, S., Mayer, T. G., et al. (2025) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000003548 · Cited by 3
Brown, T., & Filbey, F. M. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00785 · Cited by 2
“For example, THC nasal spray administered to patients with neuropathic pain resulted in improvements in subjective sleep measures [14], which is concordant with the effects of synthetic THC in patients with fibromyalgia when compared to an antidepressant [15].”
Changes in sleep quality during the 12 months following medical cannabis initiation
Short, M. M., Lent, M. R., McCalmont, T. R., et al. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00376-7 · Cited by 1
“While data from randomized controlled trials are limited given the Schedule I designation of cannabis in the United States, Ware et al. (Ware et al. 2010) found that nabilone, a synthetic cannabinoid that mimics tetrahy-drocannabinol (THC), improved sleep more effectively than amitriptyline among…”
Kurlyandchik, I., Tiralongo, E., Lauche, R., Tracey, G., Ng, J., & Schloss, J. M. (2026) · Pain Research and Management · doi:10.1155/prm/7311235 · Cited by 4
Los pros y los contras del uso de la mariguana
Villanueva, C. (2010) · Cuicuilco Revista de Ciencias Antropológicas · Cited by 4
The Ecology of Wild Cannabis sativa
Small, E. (2016) · CRC Press eBooks · doi:10.1201/9781315367583-12 · Cited by 1
Lile, J. A., Fogel, J. S., & Kelly, T. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00090-9 · Cited by 3
Beneficial Effects of Cannabis and Related Compounds on Sleep
Linares, I. M. P., Crippa, J. A. S., & Chagas, M. H. N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00106-x · Cited by 4
Cannabis — keine Empfehlung bei Fibromyalgiesyndrom?
Emrich, O. M. D. (2018) · Schmerzmedizin · doi:10.1007/s00940-018-0850-2 · Cited by 1
Fibromyalgia Syndrome and Sleep
Giorgi, V., Batticciotto, A., Rizzi, M., & Sarzi‐Puttini, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78638-0_17 · Cited by 2
Cannabis Chemistry: Cannabinoids in Cannabis, Humans, and Other Species
Small, E. (2016) · CRC Press eBooks · doi:10.1201/9781315367583-20 · Cited by 1
Appendix B: Quality Research, Evidence of Effectiveness of Medical Cannabis
(2018) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(18)30099-1 · Cited by 1
Milfortová, L. (2010) · Kontakt · doi:10.32725/kont.2010.047 · Cited by 1
Chronic Neuropathic Pain: Fibromyalgia
Miedany, Y. M. E. (2022) · Contemporary rheumatology · doi:10.1007/978-3-031-10687-3_11 · Cited by 2
Cannabidiol in the context of sleeping disorders-induced oxidative stress
Jîtcă, G., Ősz, B. E., Rusz, C.-M., Puşcaş, A., Tero-Vescan, A., Bătrînu, M.-G., & Ștefănescu, R. (2022) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2022-0023 · Cited by 2
Therapeutic application of cannabis and its derivatives
Chattopadhyay, M., Chanda, A., & Bhattacharya, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15489-8.00003-7 · Cited by 1
Imamura, M., Robertson, C., Hudson, J., Whibley, D., Aucott, L. S., Gillies, K., Beasley, M., Stevens, M., Manson, P. D., Dulake, D., et al. (2025) · Health Technology Assessment · doi:10.3310/gtbr7561 · Cited by 6
Fitzcharles, M., & Häuser, W. (2019) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-019-00130-0 · Cited by 1
Self-citationMcDonagh, M. S., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., & Chou, R. (2021) · doi:10.23970/ahrqepccerplantpain3 · Cited by 1
Cannabinoids and Pain: Clinical Evidence
MacCallum, C. A., Eadie, L., & Narouze, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_25 · Cited by 1
Martin‐Willett, R., Master, A., Bidwell, L. C., & Sznitman, S. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_70-1 · Cited by 2
Cannabinoids and the brain: New hopes for new therapies
Fernández‐Ruíz, J., Hernández, M., & García‐Movellán, Y. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch6 · Cited by 2
Hillinger, M. G., & Rosenquist, E. W. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-15820-4_11 · Cited by 1
Chou, R., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., & Selph, S. (2022) · doi:10.23970/ahrqepccannabissurveillance3 · Cited by 1
Ghafouri, N. (2013) · DiVA (Digitala Vetenskapliga Arkivet)
Likar, R. (2014) · rheuma plus · doi:10.1007/s12688-014-0110-z
TRATAMIENTO FARMACOLÓGICO RACIONAL EN LA FIBROMIALGIA
Collado, A., & Solé, E. (2014) · Cited by 3
TRATAMIENTO PSICOFARMACOLÓGICO DE LA FIBROMIALGIA.
Mayero, S. (2014) · Cited by 2
Medical cannabis: what advice should we be giving our rheumatology patients?
Fitzcharles, M., & Ste‐Marie, P. A. (2014) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.14.34
Self-citationDas Fibromyalgiesyndrom: Was hilft wirklich?
Sommer, C., Häuser, W., Alten, R. H. F., Petzke, F., Späth, M., Tölle, T. R., Üçeyler, N., Winkelmann, A., Winter, E., & Bär, K. (2013) · CME · doi:10.1007/s11298-013-0292-z
“[87] Ware MA, Fitzcharles MA, Joseph L, Shir Y (2010) The effects of nabilone on”
BackgroundNovel insights into the pathophysiology and treatment of fibromyalgia
Danneskiold‐Samsøe, B., & Bartels, E. M. (2014) · doi:10.2217/fmeb2013.13.335
Sherman, C. (2018) · TSpace (University of Toronto)
Opioids and Cannabinoids for Osteoarthritis: Either, Both, or Neither
Barbacki, A., & Fitzcharles, M. (2020) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-020-00140-3
Self-citationFibromyalgia Syndrome: Clinical Review at the Look of the Physiotherapy Academic
Barros, A. A., da Costa, H. M., do Nascimento, D. S., Neto, A. G. N., da Silva, E. C., Magalhães, S. R., de Melo, K. A. R., da Silva, L. C., da Silva, M. A. N., Tavares, V. C., et al. (2020) · International Journal of Engineering and Applied Sciences (IJEAS) · doi:10.31873/ijeas.7.01.17
The therapeutic potential of nabilone based on the results of clinical trials.
Kapała, J. M., Lewandowska, J. A., & Puchała, Ł. (2020) · Farmacja Polska · doi:10.32383/farmpol/128120
Cannabinoids promote NREM sleep via inhibition of prefrontal cortico-hypothalamic projectionsPreprint
Xu, X., Zhong, H., Xu, H., Li, X., Xie, R., Wang, Y., Li, T., Zhu, Q., Xie, J., Han, J., et al. (2020) · doi:10.21203/rs.3.rs-97925/v1
Chapter 16. Neurobiology of Marijuana
Sahlem, G. L., Sherman, B. J., & McRae‐Clark, A. L. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb16 · Cited by 1
Cannabis-Based Medicines in Fibromyalgia
Barbacki, A., & Fitzcharles, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-78638-0_20
Self-citationRole of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1818-8_18 · Cited by 1
Loewy, D. H., Poceta, J. S., & Dawson, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822963-7.00342-x
Prakash, H. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.87474
Appendix C: References (Part I)
(2018) · Journal of Nursing Regulation · doi:10.1016/s2155-8256(18)30100-5
Approved Cannabinoid Medicines for Therapeutic Use
JAMES, S. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108583336.005
„Wissen schaffen – Wissen leben“
Loock, E., Hardt, S., Kapitza, C., Krone, C., Ballenberger, N., Zalpour, C., & Tampin, B. (2021) · Der Schmerz · doi:10.1007/s00482-021-00580-3
Martin‐Willett, R., Master, A., Bidwell, L. C., & Sznitman, S. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_70 · Cited by 1
McDonagh, M. S., Wagner, J., Ahmed, A. Y., Morasco, B. J., Kansagara, D. L., & Chou, R. (2022) · doi:10.23970/ahrqepccannabissurveillance2
Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1
Singh, R. B. H., VanderPluym, J. H., Hasan, B., Farah, M. H., Viola, K. E., Saadi, S. M., Shah, S. H., Nayfeh, T., Prokop, L. J., Murad, M., et al. (2022) · doi:10.23970/ahrqepcmigrainesurveillance1 · Cited by 1
Gabapentinoids for the treatment of cannabis use disorder: A focus on human laboratory research
Lile, J. A., Stoops, W. W., & Wesley, M. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89862-1.00042-8
Opioid kullanım bozukluğu tanılı hastalarda problemli internet kullanımı ve ilişkili faktörler
Bal, N. B., & Örnek, B. Y. (2023) · Journal of Dependence · doi:10.51982/bagimli.1258814
Medical cannabis and fibromyalgia: a narrative review of current evidence
Wang, C., Erridge, S., & Sodergren, M. H. (2024) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2024.0028
Cannabinoides y dolor PARTE II
Regueras, E., Torres, L. M., & Velázquez, I. (2024) · Multidisciplinary Pain Journal · doi:10.20986/mpj.2024.1053/2023
The Elusive Truth of Cannabinoids for Rheumatic Pain
Clarke, H. A., Miles, S. J., Peer, M., & Fitzcharles, M. (2024) · Current Rheumatology Reports · doi:10.1007/s11926-024-01162-9 · Cited by 1
“These results are generally aligned with improvements in pain and sleep in previous small RCTs testing the effect of THC or nabilone (synthetic THC) in FM [69–71].”
Self-citationCannabinoids for Treating Sleep
Whibley, D., Braley, T. J., Kratz, A. L., & Boehnke, K. F. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00619-w
Valois, R. M., Silva, L. R., Shibata, L. Y., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n6-010
Fenton, C., & Fung, S. S.-P. (2025) · Drugs & Therapy Perspectives · doi:10.1007/s40267-025-01197-7
Cannabinoids in immune system-related diseases: From bench to clinic
Zhang, W., Chen, B., Cao, Y., Lei, W., Zhao, H., Yang, Y., & Tang, J. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003818
“Nabilone [107] Fibromyalgia FM patients Nabilone improves the clinical symptoms of FM patients.”
Cannabis-Based Therapies for Chronic Orofacial Pain: A Systematic Review and Meta-Analysis
Moreno, T. C., Romero-Guerrero, M., Farías, D. Q., Cevallos, S. V., Troncoso, E. P., Jaime, A. J., Chauca-Bajaña, L., Lorenzo-Pouso, A., Aguilar, H. R. Z., & Ron, B. V. (2026) · Odovtos International Journal of Dental Sciences · doi:10.15517/3e686644
“%) and no evidence of publication bias (34-35).”
Duarte, G. O., Feitosa, M. H. R., Bringel, F. D. A., et al. (2026) · EULAR Rheumatology Open · doi:10.1016/j.ero.2026.01.016
Oliveira, S. F., & das Neves, M. A. (2026) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v7i6.8047
Neuman, D. L., York, A., Gebre, M., Black, L. L., & Chadwick, A. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00099-8
The role of nabilone in pain management
Rivetti, D., & Emerick, T. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36773-1.00009-x
Joodi, S. A., Nawwar, D. A., Rasheed, N. O. A., Ibrahim, W. W., & Sayed, H. G. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02349-5
“Conversely, another RCT on nabilone demonstrated improvement in sleep quality without significant effects on pain, mood, or quality of life (Ware et al. 2010).”
Graczyk, M., Woroń, J., Białka, S., Dobrogowski, J., Doniec, Z., Gola, W., Kapala, P., Krupa, A. J., Leppert, W., Przeklasa-Muszyńska, A., et al. (2026) · Ból · doi:10.5604/01.3001.0055.8656
Metadata
- Authors
- Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y.
- Affiliations
- McGill University Health Centre (CA)
- McGill University (CA)
- Corresponding author
- Ware, Mark A.
- Shir, Yoram
- Venue
- Anesthesia & Analgesia
- Published
- 2010-02
- Volume
- 110
- Issue
- 2
- Pages
- 604-610
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W1998257682
- Semantic Scholar
- 5500e899e3f0414ac5d1d0defccd310ff047ba85
- Cited by
- 324
- References
- 34
- Citations by year
- 2026: 12 · 2025: 36 · 2024: 22 · 2023: 15 · 2022: 34 · 2021: 31 · 2020: 29 · 2019: 13 · 2018: 17 · 2017: 21 · 2016: 21 · 2015: 13 · 2014: 21 · 2013: 11 · 2012: 14
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesia & Analgesia (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Keywords
- nabilone, fibromyalgia, insomnia, sleep quality, cannabis, synthetic cannabinoids, amitriptyline, chronic pain, adverse events, drug safety and efficacy
- MeSH terms
- Adult, Aged, Amitriptyline, Antidepressive Agents, Double-Blind Method, Female, Fibromyalgia, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Pain Measurement, Sleep, Dronabinol, Anti-Anxiety Agents, Patient Satisfaction, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.